Mergers and Acquisitions in the Pharmaceutical Industry

B. Rajesh Kumar
Additional contact information
B. Rajesh Kumar: Institute of Management Technology

Chapter 1 in Mega Mergers and Acquisitions, 2012, pp 1-59 from Palgrave Macmillan

Abstract: Abstract The pharmaceutical-biotechnology industry has become increasingly concentrated over the past two decades. In 1985 the ten largest firms accounted for about 20 percent of worldwide sales, whereas in 2002 the ten largest firms accounted for 48 percent of sales. Much of this consolidation is the result of mergers. The value of mergers and acquisitions (M&A) activity in this industry exceeded $500 billion during the period 1988–2000.

Keywords: Pharmaceutical Industry; Federal Trade Commission; Therapeutic Area; Patent Expiration; Consumer Healthcare (search for similar items in EconPapers)
Date: 2012
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:pal:palchp:978-1-137-00590-8_1

Ordering information: This item can be ordered from
http://www.palgrave.com/9781137005908

DOI: 10.1057/9781137005908_1

Access Statistics for this chapter

More chapters in Palgrave Macmillan Books from Palgrave Macmillan
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().